FrancophonIA/ELRC3.0 huggingface dataset:
English: Across all placebo-controlled trials, raloxifene was indistinguishable from placebo with regard to frequency and severity of breast symptoms (no swelling, tenderness and breast pain).
Danish: I alle placebo-kontrollerede lægemiddelforsøg var der ingen forskel mellem raloxifen og placebo med hensyn til frekvens og sværhedsgrad af brystsymptomer (ingen hævelse, ømhed og brystsmerter).
English: Superficial vein thrombophlebitis occurred in a frequency of 1 % in the raloxifene group and 0.6 % in the placebo group.
Danish: Trombophlebitis i overfladiske vener forekom med en frekvens på 1 % i raloxifen-gruppen og 0,6 % i placebo-gruppen.
English: The influence of concomitant medication on raloxifene plasma concentrations was evaluated in the prevention and treatment trials.
Danish: Virkningen af samtidig medicin på raloxifen-plasmakoncentrationer blev evalueret i forsøgene til forebyggelse og behandling af osteoporose.
English: In a study comparing raloxifene with oestrogen, bone from patients treated with either medicinal product was histologically normal, with no evidence of mineralisation defects, woven bone or marrow fibrosis.
Danish: I en sammenlignende undersøgelse med raloxifen over for østrogen var patienternes knoglevæv under begge behandlinger histologisk normalt uden tegn på mineraliseringsdefekter, ikke-lamellær knogle (woven bone) eller knoglemarvsfibrose.
English: Raloxifene Teva lowers total cholesterol and LDL ("bad") cholesterol.
Danish: Raloxifen Teva sænker det samlede kolesterol og LDL (”farligt”) kolesterol.
English: In a study of 10,101 postmenopausal women with documented coronary heart disease or at increased risk for coronary events (RUTH) , the occurrence of vasodilatation (hot flushes) was 7.8 % in the raloxifene-treated patients and 4.7 % in the placebo-treated patients.
Danish: I et forsøg med 10.101 postmenopausale kvinder med dokumenteret koronar hjertesygdom eller med forhøjet risiko for koronartilfælde (RUTH), var forekomsten af vasodilation (hedeture) 7,8 % hos raloxifenbehandlede patienter og 4,7 % hos placebobehandlede patienter.
English: In female mice, an increased incidence of ovarian tumours in animals given 9 to 242 mg/kg (0.3 to 32 times the AUC in humans) included benign and malignant tumours of granulosa/theca cell origin and benign tumours of epithelial cell origin.
Danish: Hos hunmus, som fik 9 til 242 mg/kg (0,3 til 32 gange AUC hos mennesker), sås en øget forekomst af ovarietumorer, som inkluderede benigne og maligne tumorer af granulosa-/thecacelleoprindelse og benigne tumorer af epitelcelleoprindelse.
English: Raloxifene decreases resorption of bone; this effect on bone is manifested as reductions in the serum and urine levels of bone turnover markers, decreases in bone resorption based on radiocalcium kinetics studies, increases in BMD and decreases in the incidence of fractures.
Danish: Denne virkning på knoglevævet manifesteres som reduk-tioner i serum- og urinkoncentrationerne af knogleomsætningsmarkører, reduktioner i knogleresorptionen baseret på kinetiske undersøgelser med radioaktivt mærket calcium, stigninger i BMD og reduktioner i forekomsten af frakturer.
English: Flu syndrome was reported by 16.2 % of raloxifene treated patients and 14.0 % of placebo treated patients.
Danish: Influenzalignende syndrom blev rapporteret af 16,2 % af de patienter, som blev behandlet med raloxifen, og af 14,0 % af de patienter, som blev behandlet med placebo.
English: Across all placebo-controlled clinical trials of raloxifene in osteoporosis, venous thromboembolic events, including deep vein thrombosis, pulmonary embolism, and retinal vein thrombosis occurred at a frequency of approximately 0.8 % or 3.22 cases per 1,000 patient years.
Danish: I alle placebo-kontrollerede kliniske lægemiddelforsøg med raloxifen mod osteoporose forekom venøse tromboemboliske tilfælde, inklusive dyb venetrombose, lungeemboli og retinal venetrombose, med en frekvens på ca. 0,8 % eller 3,22 tilfælde pr. 1.000 patientår.
English: Teva Pharmaceutical Works Private Limited Company Pallagi út 13
Danish: Fremstillere: Teva Pharmaceutical Works Private Limited Company
English: Luxembourg/Luxemburg Teva Pharma Belgium S.A. /A.G Tél/Tel: +32 3 820 73 73
Danish: Teva Pharma Belgium S.A. /A.G Tél/Tel: +32 3 820 73 73
English: Active or past history of venous thromboembolic events (VTE), including deep vein thrombosis, pulmonary embolism and retinal vein thrombosis.
Danish: Aktive eller tidligere tilfælde af venøs tromboemboli (VTE), inklusive dyb venetrombose, lungeemboli og retinal venetrombose.
English: Tablet coating: polydextrose (E1200), titanium dioxide (E171), hypromellose (E464) and macrogol 4000.
Danish: Tabletovertræk: Polydextrose (E1200), titandioxid (E171), hypromellose (E464) og macrogol
English: In the RUTH study, venous thromboembolic events occurred at a frequency of approximately 2.0 % or 3.88 cases per 1000 patient-years in the raloxifene group and 1.4 % or 2.70 cases per 1000 patient-years in the placebo group.
Danish: I RUTH-forsøget forekom venøse tromboemboliske tilfælde med en frekvens på ca. 2,0 % eller 3,88 tilfælde pr. 1000 patientår i raloxifen-gruppen og 1,4 % eller 2,7 tilfælde pr. 1000 patientår i placebo-gruppen.
English: Do not take Raloxifene Teva - If you are allergic to raloxifene or any of the other ingredients of this medicine (listed in section
Danish: - hvis du er allergisk over for raloxifen eller et af de øvrige indholdsstoffer i dette lægemiddel (angivet i punkt 6).
English: Gastrointestinal disorders Very common: Gastrointestinal symptoms a such as nausea, vomiting, abdominal pain, dyspepsia
Danish: Meget almindelig: Gastrointestinale symptomera som kvalme, opkastning, abdominalsmerter, dyspepsi.
English: Compared with placebo-treated patients the occurrence of vasodilatation (hot flushes) was modestly increased in raloxifene patients (clinical trials for the prevention of osteoporosis, 2 to 8 years postmenopausal, 24.3 % raloxifene and 18.2 % placebo; clinical trials for the treatment of osteoporosis, mean age 66, 10.6 % for raloxifene and 7.1 % placebo).
Danish: Sammenlignet med placebo-behandlede patienter var forekomsten af vasodilatation (hedestigninger) let øget hos patienter, som blev behandlet med raloxifen (kliniske lægemiddelforsøg til forebyggelse af osteoporose, 2 til 8 år postmenopausal, 24,3 % for raloxifen og 18,2 % for placebo; kliniske lægemiddelforsøg til behandling af osteoporose, gennemsnitlig alder på 66 år, 10,6 % for raloxifen og 7,1 % for placebo).
English: In a study of postmenopausal women with documented coronary heart disease or at increased risk for coronary events, raloxifene did not affect the incidence of myocardial infarction, hospitalized acute coronary syndrome, overall mortality, including overall cardiovascular mortality, or stroke, compared to placebo.
Danish: I et forsøg med postmenopausale kvinder med dokumenteret koronar hjertesygdom eller forhøjet risiko for koronar hjertesygdom påvirkede raloxifen ikke forekomsten af hjerteinfarkt, indlæggelser med akut koronar hjertesygdom, total dødelighed, medregnet total kardiovaskulær dødelighed, eller slagtilfælde sammenlignet med placebo.
English: - If you are immobilised for some time such as being wheel-chair bound, needing to be admitted to a hospital or having to stay in bed while recovering from an operation or an unexpected illness.
Danish: Kontakt lægen eller apoteket, før du begynder at tage Raloxifen Teva: - hvis du ikke kan bevæge dig normalt i nogen tid fordi du sidder i kørestol, skal på hospitalet eller ligge i sengen efter en operation eller en uventet sygdom.
English: EU/1/10/627/003 84 film coated tablets
Danish: EU/1/10/627/001 14 filmovertrukne tabletter EU/1/10/627/002 28 filmovertrukne tabletter EU/1/10/627/003 84 filmovertrukne tabletter
English: Another adverse reaction observed was leg cramps (5.5 % for raloxifene, 1.9 % for placebo in the prevention population and 9.2 % for raloxifene, 6.0 % for placebo in the treatment population).
Danish: En anden observeret bivirkning var kramper i benene (5,5 % for raloxifen og 1,9 % for placebo blandt deltagere i forsøgene til forebyggelse og 9,2 % for raloxifen og 6,0 % for placebo blandt deltagere i forsøgene til behandling).
English: Although it may have no symptoms at first, osteoporosis makes you more likely to break bones, especially in your spine, hips and wrists and may cause back pain, loss of height and a curved back.
Danish: Selvom knogleskørhed i begyndelsen ikke giver symptomer, kan den øge risikoen for, at du brækker dine knogler, specielt rygsøjlen, hofterne og håndleddene.
English: The incidence of stroke mortality was 1.5 per 1000 women per year for placebo versus 2.2 per 1000 women per year for raloxifene.
Danish: Hyppigheden af død som følge af slagtilfælde var 1,5 pr. 1000 kvinder pr. år for placebo mod 2,2 pr. 1000 kvinder pr. år for raloxifen.
English: Uncommon: Venous thromboembolic events, including deep vein thrombosis, pulmonary embolism, retinal vein thrombosis, superficial vein thrombophlebitis, Arterial thromboembolic reactions a
Danish: Ikke almindelig: Venøse tromboemboliske tilfælde, inklusive dyb venetrombose, lungeemboli, retinal venetrombose, tromboflebitis i overfladiske vener, arterielle tromboemboliske bivirkningera
English: Other medicines and Raloxifene Teva
Danish: Brug af anden medicin sammen med Raloxifen Teva
English: Pregelatinized starch (maize) Magnesium stearate Povidone (K30)
Danish: Prægelatineret stivelse (majs) Magnesiumstearat
English: • Increased risk of blood clots in the legs (deep vein thrombosis).
Danish: • Øget risiko for blodpropper i benene (dyb venetrombose).
English: In the RUTH study, peripheral oedema occurred in 14.1 % of the raloxifene-treated patients and 11.7 % of the placebo-treated patients, which was statistically significant.
Danish: I RUTH-forsøget forekom perifert ødem hos 14,1 % af de raloxifen-behandlede patienter og hos 11,7 % af de placebo-behandlede patienter, hvilket var statistisk signifikant.
English: In a study (RUTH) of postmenopausal women with documented coronary heart disease or at increased risk for coronary events, an additional adverse reaction of cholelithiasis occurred in 3.3 % of patients treated with raloxifene and 2.6 % of patients treated with placebo.
Danish: I et forsøg (RUTH) med postmenopausale kvinder med dokumenteret koronar hjertesygdom eller med forhøjet risiko for koronartilfælde, sås cholelithiasis som en yderligere bivirkning hos 3,3 % af de patienter, der blev behandlet med raloxifen, mens tallet var 2,6 % for patienterne, der fik placebo.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/10/627/001-003
Danish: EU/1/10/627/001-003
English: Limited clinical data suggest that in patients with a history of oral oestrogen-induced hypertriglyceridemia (> 5.6 mmol/l), raloxifene may be associated with a marked increase in serum triglycerides.
Danish: Begrænsede kliniske data tyder på at raloxifen kan være forbundet med en mærkbar øgning i serumtriglycerid hos patienter, der tidligere har haft oral østrogeninduceret hypertriglyceridæmi (> 5,6 mmol/l).
English: In a study of 7,705 postmenopausal women with a mean age of 66 years and with osteoporosis or osteoporosis with an existing fracture, raloxifene treatment for 3 years reduced the incidence of vertebral fractures by 47 % (RR 0.53, CI 0.35, 0.79; p < 0.001) and 31 % (RR 0.69, CI 0.56, 0.86; p < 0.001) respectively.
Danish: I en undersøgelse af 7.705 postmenopausale kvinder med en gennemsnitlig alder på 66 år og med osteoporose eller osteoporose med en eksisterende fraktur, reducerede 3 års behandling med raloxifen forekomsten af vertebrale frakturer med henholdsvis 47 % (relativ risiko 0,53, konfidensinterval 0,35-0,79; p < 0,001) og 31 % (relativ risiko 0,69, konfidensinterval 0,56-0,86; p < 0,001).
English: Raloxifene is only for use in postmenopausal women.
Danish: Graviditet Raloxifen må kun anvendes af postmenopausale kvinder.
English: Similarly, in the RUTH study, raloxifene did not affect the incidence of myocardial infarction, hospitalized acute coronary syndrome, stroke or overall mortality, including overall cardiovascular mortality, compared to placebo (for the increase in risk of fatal stroke see section 4.4).
Danish: Tilsvarende sås i RUTH-forsøget, at raloxifen ikke påvirkede hyppigheden af hjerteinfarkt, indlæggelse på grund af akut hjertesygdom, slagtilfælde eller samlet dødelighed, inklusive samlet kardiovaskulær dødelighed set i forhold til placebo (for forhøjet risiko for fatalt slagtilfælde, se pkt.
English: th year alone, raloxifene reduced the new vertebral fracture risk by 39 % (RR 0.61, CI 0.43, 0.88).
Danish: I det fjerde år alene reducerede raloxifen risikoen for nye vertebrale frakturer med 39 % (relativ risiko 0,61, konfidensinterval 0,43-0,88).
English: Raloxifene should not be used in patients with severe renal impairment (see section 4.3).
Danish: Raloxifen bør ikke anvendes til patienter med svært nedsat nyrefunktion (se pkt.
English: As safety information regarding co-administration of raloxifene with systemic oestrogens, is limited, such use is not recommended.
Danish: Information omkring sikkerhed ved samtidig administration af raloxifen og systemisk østrogen er begrænset.
English: - If you have liver disease (examples of liver disease include cirrhosis, mild hepatic impairment or cholestatic jaundice).
Danish: - hvis du har en leversygdom (eksempler på leversygdomme omfatter skrumpelever, let nedsat leverfunktion og gulsot på grund af afløbshindring).
English: The recommended dose is one tablet daily.Due to the nature of this disease process, raloxifene is intended for long term use.
Danish: Raloxifen er beregnet til langvarig brug på grund af karakteren af sygdomsprocessen.
English: Raloxifene produced significant increases in bone density of hip and spine as well as total body mineral mass compared to placebo.
Danish: Raloxifen øgede knoglemineraltætheden i hofte og rygsøjle samt knoglemassen i hele kroppen signifikant i forhold til placebo.
English: The relative risk of venous thromboembolic events observed during raloxifene treatment was 1.60 (CI 0.95, 2.71) when compared to placebo, and was 1.0 (CI 0.3, 6.2) when compared to oestrogen or hormonal replacement therapy.
Danish: Den relative risiko for venøse tromboemboliske tilfælde, som er observeret under raloxifen-behandling, var 1,60 (konfidensinterval 0,95-2,71) i forhold til placebo og 1,0 (konfidensinterval 0,3-6,2) i forhold til østrogen eller hormonal substitutionsterapi.
English: In the prevention population discontinuations of therapy due to any adverse reaction occurred in 10.7 % of 581 raloxifene treated patients and 11.1 % of 584 placebo-treated patients.
Danish: Blandt deltagere i forsøgene til forebyggelse af osteoporose forekom behandlingsophør som følge af enhver bivirkning hos 10,7 % af 581 raloxifen-behandlede patienter og hos 11,1 % af 584 placebobehandlede patienter.
English: Raloxifene Teva 60 mg film-coated tablets raloxifene hydrochloride
Danish: Raloxifen Teva 60 mg filmovertrukne tabletter raloxifenhydrochlorid
English: In the RUTH study, leg cramps were observed in 12.1 % of raloxifene-treated patients and 8.3 % of placebo-treated patients.
Danish: I RUTH-forsøget blev kramper i benene observeret hos 12,1 % af de raloxifen-behandlede patienter og hos 8,3 % af de placebo-behandlede patienter.
English: Raloxifene Teva reduces the risk of vertebral fractures in women with postmenopausal osteoporosis.
Danish: Raloxifen Teva nedsætter risikoen for brud på rygsøjlen hos kvinder med knogleskørhed efter overgangsalderen.
English: • Increased risk of blood clots in the eyes (retinal vein thrombosis).
Danish: • Øget risiko for blodproper i øjet (nethinde-venetrombose).
English: Each film-coated tablet contains 60 mg raloxifene hydrochloride, equivalent to 56 mg raloxifene.
Danish: Hver filmovertrukken tablet indeholder 60 mg raloxifenhydrochlorid, hvilket svarer til 56 mg raloxifen.
English: INFORMATION IN BRAILLE Raloxifene Teva 60 mg
Danish: Raloxifen Teva 60 mg
English: Raloxifene treated women consistently had an endometrial thickness which was indistinguishable from placebo.
Danish: Raloxifen-behandlede kvinder havde en endometrietykkelse, som ikke var forskellig fra placebo.
English: Raloxifene treatment for 4 years reduced the incidence of vertebral fractures by 46 % (RR 0.54, CI 0.38, 0.75) and 32 % (RR 0.68, CI 0.56, 0.83) in patients with osteoporosis or osteoporosis with an existing fracture respectively.
Danish: Behandling med raloxifen i 4 år reducerede forekomsten af vertebrale frakturer med 46 % (relativ risiko 0,54, konfidensinterval 0,38-0,75) og 32 % (relativ risiko 0,68, konfidensinterval 0,56-0,83) hos patienter med henholdsvis osteoporose eller osteoporose med en eksisterende fraktur.
English: In rats retardation of foetal development, wavy ribs and kidney cavitation occurred (≥ 1 mg/kg).
Danish: Hos rotter forekom forsinket fosterudvikling, bølgeformede ribben og hulheder i nyrer (≥ 1 mg/kg).
English: This was peripheral oedema, which occurred in the prevention population at an incidence of 3.1 % for raloxifene and 1.9 % for placebo; and in the treatment population occurred at an incidence of 7.1 % for raloxifene and 6.1 % for placebo.
Danish: Dette var perifert ødem, som forekom med en hyppighed på 3,1 % for raloxifen og 1,9 % for placebo blandt deltagere i forsøgene til forebyggelse og med en hyppighed på 7,1 % for raloxifen og 6,1 % for placebo blandt deltagere i forsøgene til behandling.
English: - If you have any unexplained vaginal bleeding.
Danish: hvis du af ukendt årsag har blødning fra underlivet.
English: - If you are receiving oral oestrogen therapy.
Danish: - hvis du tager hormontabletter med østrogen.
English: Patients with hepatic impairment:
Danish: Patienter med nedsat nyrefunktion
English: Over the 4 years of the osteoporosis treatment trial (involving 7705 patients), raloxifene treatment compared to placebo reduced the risk of total breast cancer by 62 % (RR 0.38; CI 0.21, 0.69), the risk of invasive breast cancer by 71 % (RR 0.29, CI 0.13, 0.58) and the risk of invasive oestrogen receptor (ER) positive breast cancer by 79 % (RR 0.21, CI 0.07, 0.50).
Danish: I løbet af de 4 års osteoporosebehandlingsforsøg (med 7705 patienter), reducerede raloxifen-behandling risikoen for brystcancer i forhold til placebo med 62 % (relativ risiko 0,38, konfidensinterval 0,21-0,69), risikoen for invasiv brystcancer med 71 % (relativ risiko 0,29, konfidensinterval 0,13-0,58) samt risikoen for invasiv østrogenreceptor-positiv brystcancer med 79 % (relativ risiko 0,21, konfidensinterval 0,07-0,50).
English: In the treatment population discontinuations of therapy due to any clinical adverse event occurred in 12.8 % of 2,557 raloxifene treated patients and 11.1 % of 2,576 placebo treated patients.
Danish: Blandt deltagere i forsøgene til behandling af osteoporose forekom behandlingsophør som følge af enhver bivirkning hos 12,8 % af 2.557 raloxifen-behandlede patienter og hos 11,1 % af 2.576 placebo-behandlede patienter.
English: Each film-coated tablet contains 60 mg raloxifene hydrochloride, equivalent to 56 mg raloxifene free base.
Danish: Hver filmovertrukken tablet indeholder 60 mg raloxifenhydrochlorid svarende til 56 mg raloxifen fri base.
English: - If you have had a cerebrovascular accident (e.g. stroke), or if your doctor has told you that you are at high risk of having one.
Danish: - hvis du har haft et slagtilfælde, eller hvis din læge har fortalt dig, at du har høj risiko for at få et. - hvis du har leverproblemer, da der er utilstrækkelig erfaring hos mennesker med leverproblemer.
English: Uncommon (may affect up to 1 in 100 people)
Danish: Almindelig (kan ramme 1 til 10 ud af 100 patienter)
English: Driving and using machines Raloxifene Teva has no or negligible effects on driving or using machines.
Danish: Raloxifen Teva påvirker ikke eller kun i ubetydelig grad evnen til at køre bil eller betjene maskiner.
English: The incidence of stroke mortality was 2.2 per 1,000 women per year for raloxifene versus 1.5 per 1,000 women per year for placebo (see section 4.4).
Danish: Hyppigheden af død som følge af apopleksi var 2,2 pr. 1.000 kvinder pr. år for raloxifen mod 1,5 pr. 1.000 kvinder pr. år for placebo (se pkt.
English: Fewer raloxifene treated women than placebo treated women required surgical intervention for uterine prolapse.
Danish: Færre raloxifen-behandlede kvinder havde behov for et operativt indgreb for uterint prolaps end placebo-behandlede kvinder.
English: • Leg cramps.
Danish: • Kramper i benene.
English: How to take Raloxifene Teva
Danish: Sådan skal du tage Raloxifen Teva
English: • Mild breast symptoms such as pain, enlargement and tenderness
Danish: • Lette symptomer i brystet, såsom smerter, hævelse, ømhed.
English: ATC code: G03XC01 Mechanism of action and Pharmacodynamic effect As a selective oestrogen receptor modulator (SERM), raloxifene has selective agonist or antagonist activities on tissues responsive to oestrogen.
Danish: Som en selektiv østrogenreceptormodulator (SERM) har raloxifen selektiv agonistisk eller antagonistisk effekt på væv, som påvirkes af østrogen.
English: In patients with moderate and mild renal impairment, raloxifene should be used with caution.
Danish: Raloxifen bør anvendes med forsigtighed til patienter med moderat til mild nedsat nyrefunktion.
English: • Skin around the vein is red and painful (superficial vein thrombophlebitis).
Danish: • Rød og smertende hud omkring en vene (årebetændelse med blodprop i huden).
English: Raloxifene Teva does not treat postmenopausal symptoms, such as hot flushes.
Danish: Raloxifen Teva kan ikke lindre symptomer, såsom hedestigninger, som opstår i forbindelse med overgangsalderen.
English: If you wish you may take a glass of water with it.
Danish: Du bør synke tabletten med et glas vand eller anden væske.
English: No cases of raloxifene overdose were reported during clinical trials.
Danish: I de kliniske forsøg var der ikke rapporter om tilfælde med overdosering af raloxifen.
English: Blood and lymphatic system disorders Uncommon: Thrombocytopenia a
Danish: Ikke almindelig: Trombocytopenia
English: NAME OF THE MEDICINAL PRODUCT Raloxifene Teva 60 mg film-coated tablets raloxifene hydrochloride
Danish: Indlægsseddel: Information til brugeren Raloxifen Teva 60 mg filmovertrukne tabletter raloxifenhydrochlorid
English: There is no relevant use of Raloxifene in the paediatric population.
Danish: Raloxifen bør ikke anvendes til børn uanset alder. Der er ingen relevante indikationer for raloxifen i den pædiatriske population.
English: How to store Raloxifene Teva Contents of the pack and other information
Danish: Pakningsstørrelser og yderligere oplysninger Raloxifen Teva indeholder:
English: What you need to know before you take Raloxifene Teva
Danish: Det skal du vide, før du begynder at tage Raloxifen Teva Tag ikke Raloxifen Teva
English: If you take more Raloxifene Teva than you should you could have leg cramps and dizziness.
Danish: Du kan få kramper i benene eller blive svimmel, hvis du har taget flere Raloxifen Teva, end du skal.
English: The clinically most important adverse reactions reported in postmenopausal women treated with Raloxifen were venous thromboembolic events (see section 4.4), which occurred in less than 1% of treated patients.
Danish: De vigtigste, kliniske bivirkning, som er rapporteret hos postmenopausale kvinder behandlet med raloxifen, var venøse tromboemboliske hændelser (se pkt.
English: What Raloxifene Teva is and what it is used for What you need to know before you take Raloxifene Teva How to take Raloxifene Teva Possible side effects
Danish: Det skal du vide, før du begynder at tage Raloxifen Teva Sådan skal du tage Raloxifen Teva Bivirkninger
English: Osteoporosis is a disease that causes your bones to become thin and fragile - this disease is especially common in women after the menopause.
Danish: Knogleskørhed er en sygdom, som gør dine knogler tynde og skrøbelige.